• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部乳腺微生物群:该领域的“新”参与者。

Local Breast Microbiota: A "New" Player on the Block.

作者信息

Vitorino Marina, Alpuim Costa Diogo, Vicente Rodrigo, Caleça Telma, Santos Catarina

机构信息

Medical Oncology Department, Hospital Professor Doutor Fernando Fonseca, 2720-276 Amadora, Portugal.

Breast Cancer Unit, CUF Oncologia, 1998-018 Lisbon, Portugal.

出版信息

Cancers (Basel). 2022 Aug 5;14(15):3811. doi: 10.3390/cancers14153811.

DOI:10.3390/cancers14153811
PMID:35954474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367283/
Abstract

The tumour microenvironment (TME) comprises a complex ecosystem of different cell types, including immune cells, cells of the vasculature and lymphatic system, cancer-associated fibroblasts, pericytes, and adipocytes. Cancer proliferation, invasion, metastasis, drug resistance and immune escape are all influenced by the dynamic interaction between cancer cells and TME. Microbes, such as bacteria, fungi, viruses, archaea and protists, found within tumour tissues, constitute the intratumour microbiota, which is tumour type-specific and distinct among patients with different clinical outcomes. Growing evidence reveals a significant relevance of local microbiota in the colon, liver, breast, lung, oral cavity and pancreas carcinogenesis. Moreover, there is a growing interest in the tumour immune microenvironment (TIME) pointed out in several cross-sectional studies on the correlation between microbiota and TME. It is now known that microorganisms have the capacity to change the density and function of anticancer and suppressive immune cells, enabling the promotion of an inflammatory environment. As immunotherapy (such as immune checkpoint inhibitors) is becoming a promising therapy using TIME as a therapeutic target, the analysis and comprehension of local microbiota and its modulating strategies can help improve cancer treatments.

摘要

肿瘤微环境(TME)由不同细胞类型组成的复杂生态系统构成,包括免疫细胞、血管和淋巴系统细胞、癌症相关成纤维细胞、周细胞和脂肪细胞。癌细胞与TME之间的动态相互作用会影响癌症的增殖、侵袭、转移、耐药性和免疫逃逸。肿瘤组织中发现的微生物,如细菌、真菌、病毒、古菌和原生生物,构成了肿瘤内微生物群,它具有肿瘤类型特异性,且在具有不同临床结果的患者中有所不同。越来越多的证据表明,结肠、肝脏、乳腺、肺、口腔和胰腺的局部微生物群与癌症发生密切相关。此外,在几项关于微生物群与TME相关性的横断面研究中,人们对肿瘤免疫微环境(TIME)的兴趣日益浓厚。现在已知微生物有能力改变抗癌和抑制性免疫细胞的密度和功能,从而促进炎症环境的形成。由于免疫疗法(如免疫检查点抑制剂)正成为一种以TIME为治疗靶点的有前景的疗法,对局部微生物群及其调节策略的分析和理解有助于改善癌症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c2/9367283/50c8859bb386/cancers-14-03811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c2/9367283/8268cc270036/cancers-14-03811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c2/9367283/50c8859bb386/cancers-14-03811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c2/9367283/8268cc270036/cancers-14-03811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c2/9367283/50c8859bb386/cancers-14-03811-g002.jpg

相似文献

1
Local Breast Microbiota: A "New" Player on the Block.局部乳腺微生物群:该领域的“新”参与者。
Cancers (Basel). 2022 Aug 5;14(15):3811. doi: 10.3390/cancers14153811.
2
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.微生物群辅助的肿瘤微环境:乳腺癌的新兴靶点
Clin Breast Cancer. 2022 Apr;22(3):200-211. doi: 10.1016/j.clbc.2021.09.002. Epub 2021 Sep 12.
3
Understanding and harnessing triple-negative breast cancer-related microbiota in oncology.肿瘤学中对三阴性乳腺癌相关微生物群的理解与利用
Front Oncol. 2022 Nov 24;12:1020121. doi: 10.3389/fonc.2022.1020121. eCollection 2022.
4
Immune System Efficiency in Cancer and the Microbiota Influence.免疫系统效率与癌症和微生物组的影响。
Pathobiology. 2021;88(2):170-186. doi: 10.1159/000512326. Epub 2021 Feb 15.
5
Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.促甲状腺滤泡癌细胞间通讯中断可作为免疫治疗机会
Adv Exp Med Biol. 2021;1350:33-66. doi: 10.1007/978-3-030-83282-7_2.
6
Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.肿瘤微环境与一氧化氮:概念与机制。
Adv Exp Med Biol. 2020;1277:143-158. doi: 10.1007/978-3-030-50224-9_10.
7
The Intestinal Tumour Microenvironment.肠道肿瘤微环境。
Adv Exp Med Biol. 2020;1226:1-22. doi: 10.1007/978-3-030-36214-0_1.
8
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.共生微生物群有助于预测非小细胞肺癌患者对免疫检查点抑制剂的反应。
Cancer Sci. 2021 Aug;112(8):3005-3017. doi: 10.1111/cas.14979. Epub 2021 Jun 23.
9
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
10
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.探索肠道微生物群和肿瘤微环境在癌症免疫治疗中的新兴作用。
Front Immunol. 2021 Jan 7;11:612202. doi: 10.3389/fimmu.2020.612202. eCollection 2020.

引用本文的文献

1
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.利用肿瘤内微生物群:免疫微环境与免疫治疗的新视野
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
2
Integrated spatial multi-omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression.乳腺癌中具核梭杆菌的综合空间多组学分析揭示了其在肿瘤微环境调节和癌症进展中的作用。
Clin Transl Med. 2025 Mar;15(3):e70273. doi: 10.1002/ctm2.70273.
3
Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment.

本文引用的文献

1
Roles of Microbiota in Cancer: From Tumor Development to Treatment.微生物群在癌症中的作用:从肿瘤发展到治疗
J Oncol. 2022 Mar 23;2022:3845104. doi: 10.1155/2022/3845104. eCollection 2022.
2
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment.抗血管生成治疗、免疫治疗及肿瘤微环境的研究进展。
Front Immunol. 2022 Feb 23;13:802846. doi: 10.3389/fimmu.2022.802846. eCollection 2022.
3
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study.
肠道微生物群在乳腺癌发展中的新作用及其对治疗的影响
Metabolites. 2024 Dec 5;14(12):683. doi: 10.3390/metabo14120683.
4
The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications.乳腺癌中的口腔-肠道微生物群轴:从基础研究到治疗应用
Front Cell Infect Microbiol. 2024 Nov 21;14:1413266. doi: 10.3389/fcimb.2024.1413266. eCollection 2024.
5
The Influence of Microbiota on Breast Cancer: A Review.微生物群对乳腺癌的影响:综述
Cancers (Basel). 2024 Oct 13;16(20):3468. doi: 10.3390/cancers16203468.
6
The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.新兴的肿瘤微生物微环境:从界定到基于多学科方法的干预措施。
Acta Pharm Sin B. 2024 Apr;14(4):1560-1591. doi: 10.1016/j.apsb.2023.11.018. Epub 2023 Nov 15.
7
Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours.肠道微生物群和饮食在结直肠癌和乳腺癌的发生及进展中的作用以及两种肿瘤之间的相互联系。
Microbiome Res Rep. 2023 Nov 27;3(1):6. doi: 10.20517/mrr.2023.36. eCollection 2024.
8
Current and future research on the association between gut microbiota and breast cancer.肠道微生物群与乳腺癌关联的当前及未来研究
Front Microbiol. 2023 Oct 30;14:1272275. doi: 10.3389/fmicb.2023.1272275. eCollection 2023.
9
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?细胞周期特异性抗癌药物的药物微生物组学——这是癌症患者个体化治疗的新视角吗?
Gut Microbes. 2023 Dec;15(2):2281017. doi: 10.1080/19490976.2023.2281017. Epub 2023 Nov 20.
10
Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue.社论:“构建肿瘤免疫微环境”特刊
Cancers (Basel). 2023 Aug 8;15(16):4014. doi: 10.3390/cancers15164014.
三阴性、早期高危及局部晚期乳腺癌新辅助治疗(无论是否联合阿替利珠单抗)的病理完全缓解(pCR):NeoTRIP米开朗基罗随机研究
Ann Oncol. 2022 May;33(5):534-543. doi: 10.1016/j.annonc.2022.02.004. Epub 2022 Feb 17.
4
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice.用于血液学和肿瘤学疾病的粪便微生物群移植:原理与实践
Cancers (Basel). 2022 Jan 29;14(3):691. doi: 10.3390/cancers14030691.
5
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments.乳腺癌中的人类微生物群与免疫疗法——近期进展综述
Front Oncol. 2022 Jan 28;11:815772. doi: 10.3389/fonc.2021.815772. eCollection 2021.
6
The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.人类微生物组在肿瘤发生、癌症进展和生物治疗开发中的影响。
BMC Microbiol. 2022 Feb 12;22(1):53. doi: 10.1186/s12866-022-02465-6.
7
Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity.肠道微生物群与宿主微小RNA在结直肠癌和乳腺癌发生中的相互作用及其对患者免疫的影响。
Onco Targets Ther. 2021 Oct 22;14:5115-5129. doi: 10.2147/OTT.S329383. eCollection 2021.
8
The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?肿瘤微生物微环境在肿瘤免疫微环境中的作用:旁观者、激活剂还是抑制剂?
J Exp Clin Cancer Res. 2021 Oct 16;40(1):327. doi: 10.1186/s13046-021-02128-w.
9
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.PD-L1 抑制性 microRNAs 治疗三阴性乳腺癌的系统评价:迈向单细胞测序指导的仿生递药。
Genes (Basel). 2021 Aug 4;12(8):1206. doi: 10.3390/genes12081206.
10
Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment.肿瘤微环境中肠道微生物群与肿瘤免疫的相互作用。
Immunology. 2021 Nov;164(3):476-493. doi: 10.1111/imm.13397. Epub 2021 Sep 26.